HCA Healthcare Overview
HCA Healthcare Target Price
Analysts' 12-month price predictions for HCA.
Share Price
$411.59
Average Target Price
$409.00
0.6% downside
0.6% downside3 analysts in the last 4 months
High: $416 | Low: $401
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-07-28 | RBC CapitalBen Hendrix | $401 | 2.6% downside |  |
| 2025-06-09 | Morgan StanleyCraig Hettenbach | $410 | 0.4% downside | |
| 2025-06-02 | BarclaysAndrew Mok | $416 |  1.1% upside | |
| 2025-01-07 | KeyBancMatthew Gillmor | $370 | 10.1% downside | |
| 2024-10-28 | OppenheimerMichael Wiederhorn | $400 | 2.8% downside | |
| 2024-10-28 | KeyBancMatthew Gillmor | $420 | 2% upside | |
| 2024-10-28 | Mizuho SecuritiesAnn Hynes | $425 | 3.3% upside | |
| 2024-10-10 | KeyBancMatthew Gillmor | $475 | 15.4% upside | |
| 2024-10-01 | Deutsche BankPito Chickering | $441 | 7.1% upside | |
| 2024-08-19 | Truist FinancialDavid MacDonald | $430 | 4.5% upside | |
| 2024-06-28 | Deutsche BankPito Chickering | $375 | 8.9% downside | |
| 2024-06-06 | JefferiesBrian Tanquilut | $390 | 5.2% downside | |
| 2024-04-29 | RBC CapitalBen Hendrix | $329 | 20.1% downside | |
| 2024-04-29 | OppenheimerMichael Wiederhorn | $345 | 16.2% downside | |
| 2024-04-12 | Deutsche BankPito Chickering | $359 | 12.8% downside | |
| 2023-04-24 | RBC CapitalBen Hendrix | $315 | 23.5% downside | |
| 2023-04-24 | OppenheimerMichael Wiederhorn | $310 | 24.7% downside | |
| 2023-04-24 | Mizuho SecuritiesAnn Hynes | $298 | 27.6% downside | |
| 2023-02-08 | Goldman Sachs | $296 | 28.1% downside | |
| 2023-01-13 | UBS | $296 | 28.1% downside | |
| 2023-01-03 | Wells Fargo | $243 | 41% downside | |
| 2022-12-16 | Leerink Partners | $286 | 30.5% downside | |
| 2022-12-12 | Goldman Sachs | $265 | 35.6% downside | |
| 2022-09-16 | Raymond James | $250 | 39.3% downside | |
| 2022-08-24 | Leerink Partners | $259 | 37.1% downside | |
| 2022-08-16 | Mizuho SecuritiesAnn Hynes | $230 | 44.1% downside | |
| 2022-07-28 | Wells Fargo | $199 | 51.7% downside | |
| 2022-07-26 | Raymond James | $230 | 44.1% downside | |
| 2022-07-25 | RBC Capital | $249 | 39.5% downside | |
| 2022-07-25 | Credit Suisse | $250 | 39.3% downside | |
| 2022-07-25 | Truist Financial | $240 | 41.7% downside | |
| 2022-07-25 | Leerink Partners | $240 | 41.7% downside | |
| 2022-07-15 | Leerink Partners | $212 | 48.5% downside | |
| 2022-07-12 | Goldman Sachs | $233 | 43.4% downside | |
| 2022-07-11 | Raymond James | $220 | 46.5% downside | |
| 2022-07-07 | Deutsche Bank | $200 | 51.4% downside | |
| 2022-07-01 | Mizuho Securities | $210 | 49% downside | |
| 2022-06-21 | RBC Capital | $256 | 37.8% downside | |
| 2022-06-16 | Loop Capital MarketsJoseph France | $240 | 41.7% downside | |
| 2022-05-03 | Mizuho Securities | $260 | 36.8% downside | |
| 2022-04-28 | BMO CapitalMatt Borsch | $240 | 41.7% downside | |
| 2022-04-26 | UBS | $241 | 41.4% downside | |
| 2022-04-26 | Raymond James | $245 | 40.5% downside | |
| 2022-04-25 | Truist Financial | $250 | 39.3% downside | |
| 2022-04-25 | Wells Fargo | $227 | 44.8% downside | |
| 2022-04-25 | Credit Suisse | $260 | 36.8% downside | |
| 2022-04-25 | Leerink Partners | $273 | 33.7% downside | |
| 2022-04-25 | Citigroup | $254 | 38.3% downside | |
| 2022-04-25 | RBC Capital | $267 | 35.1% downside | |
| 2022-04-25 | Wells FargoSteve Baxter | $227 | 44.8% downside | |